Put Options

13 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2023

Nov 14, 2023

SELL
$191.51 - $216.16 $4.06 Million - $4.58 Million
-21,200 Reduced 19.13%
89,600 $19 Million
Q2 2023

Aug 14, 2023

BUY
$187.64 - $206.25 $8.91 Million - $9.8 Million
47,500 Added 75.04%
110,800 $21.3 Million
Q1 2023

May 15, 2023

BUY
$127.59 - $203.08 $8.08 Million - $12.9 Million
63,300 New
63,300 $12.8 Million
Q2 2022

Aug 15, 2022

SELL
$108.81 - $179.33 $10,881 - $17,933
-100 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$119.61 - $157.85 $11,961 - $15,785
100 New
100 $14,000
Q4 2021

Feb 14, 2022

SELL
$142.57 - $190.86 $128,313 - $171,774
-900 Reduced 45.0%
1,100 $168,000
Q4 2021

Feb 14, 2022

SELL
$142.57 - $190.86 $156,827 - $209,946
-1,100 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$142.45 - $169.82 $284,900 - $339,640
2,000 New
2,000 $340,000
Q3 2021

Nov 15, 2021

SELL
$142.45 - $169.82 $113,959 - $135,856
-800 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$135.08 - $161.1 $108,064 - $128,880
800 New
800 $127,000
Q1 2021

May 14, 2021

SELL
$137.51 - $190.8 $1.53 Million - $2.12 Million
-11,100 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$137.51 - $190.8 $715,052 - $992,160
-5,200 Reduced 31.9%
11,100 $1.54 Million
Q4 2020

Feb 16, 2021

BUY
$164.63 - $211.93 $2.68 Million - $3.45 Million
16,300 New
16,300 $2.86 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Parallax Volatility Advisers, L.P. Portfolio

Follow Parallax Volatility Advisers, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.